These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. How we approach coagulopathy with vascular anomalies. Mack JM; Crary SE Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29353. PubMed ID: 36070211 [TBL] [Abstract][Full Text] [Related]
13. Venous malformations with severe localized intravascular coagulopathy treated with microwave ablation. Tai MZ; Wang YP; Chen T; Li KL; Xu ZG; Ge CX; Qin ZP; Zheng JW Vascular; 2022 Aug; 30(4):779-786. PubMed ID: 34144653 [TBL] [Abstract][Full Text] [Related]
14. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Ali S; Weiss CR; Sinha A; Eng J; Mitchell SE Phlebology; 2016 Oct; 31(9):603-9. PubMed ID: 27009607 [TBL] [Abstract][Full Text] [Related]
16. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience. Li L; Feng J; Zeng XQ; Li YH J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886 [TBL] [Abstract][Full Text] [Related]
17. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up. James CA; Braswell LE; Wright LB; Roberson PK; Moore MB; Waner M; Buckmiller LM J Vasc Interv Radiol; 2011 Jul; 22(7):953-60. PubMed ID: 21550819 [TBL] [Abstract][Full Text] [Related]
18. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol. Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546 [TBL] [Abstract][Full Text] [Related]
19. Giant intrahepatic venous malformation with localized intravascular coagulopathy. Follow-up and treatment during pregnancy. Serrano F; Bisdorff-Bresson A; Sroussi J; Aymard A; Wassef M; Civelli V; Boujlel S; Houdart E; Drouet L J Med Vasc; 2020 Dec; 45(6):309-315. PubMed ID: 33248533 [TBL] [Abstract][Full Text] [Related]
20. Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations. Ardillon L; Lambert C; Eeckhoudt S; Boon LM; Hermans C Blood Coagul Fibrinolysis; 2016 Mar; 27(2):216-9. PubMed ID: 26484645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]